Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma.
Saved in:
| Title: | Time-dependent prognostic value of automated Ki67 assessment and its integration with molecular risk profiling in WHO grade 2 meningioma. |
|---|---|
| Authors: | Voßbeck L; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Ehret F; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, A Partnership Between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany., Perez E; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Radbruch H; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Hain EG; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Schmid S; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Onken J; Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Bohn M; Institute of Neurology (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Salman N; Department of Radiation Oncology, Health and Medical University Potsdam, Olympischer Weg 1, 14471, Potsdam, Germany., Schweizer L; Institute of Neurology (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany., Capper D; German Cancer Consortium (DKTK), Partner Site Berlin, A Partnership Between DKFZ and Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Zu Berlin, Berlin, Germany., Armbrust M; Institute of Neurology (Edinger Institute), Goethe University Frankfurt, University Hospital, Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT), Frankfurt am Main, Germany., Kaul D; Department of Radiation Oncology, Health and Medical University Potsdam, Olympischer Weg 1, 14471, Potsdam, Germany. david.kaul@hmu-potsdam.de. |
| Source: | Acta neuropathologica communications [Acta Neuropathol Commun] 2026 Jul 27; Vol. 14 (1). Date of Electronic Publication: 2026 Jul 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101610673 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-5960 (Electronic) Linking ISSN: 20515960 NLM ISO Abbreviation: Acta Neuropathol Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
